TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CDXS

Codexis Inc

Healthcare · Biotechnology

1.40$ +3.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Codexis Inc (CDXS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CDXS
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-13 -6.5 -36 -8.7 -16 -0.5 -12 -23 0.3 -0.4 -2.7 -8.8 -14 -13 -16 -14 11 -53 -49 -19
2.4 2.9 4.6 6.1 8.3 11 12 10 6.7 5.4 4.5 1.0 1.1 4.6 4.6 5.9 10 9.9 4.9 5.2
0.1 1.3 3.5 4.8 8.7 9.4 5.1 4.4 4.6 5.1 5.7 7.1 7.9 6.9 7.7 12 15 10.0 13 9.6
9.5 6.6 6.0 5.8 5.2 5.6 6.9 8.0 7.5 7.8 8.7 13
2.7 26 1.0 -1.0 -27 -5.6 -1.4 2.0 6.2 -3.1 -4.3 6.3 -12 -13 -3.9 -7.6 22 -18 -12 6.4
1.1 8.2 8.5 11 28 11 2.9 1.2 0.3 1.2 0.9 1.0 2.8 3.7 3.7 14 8.3 4.4 4.3 4.5
0.2 -39 7.1 -21 -5.2 -49 17 13 4.6 -1.3 -0.8 -0.9 -2.8 -3.7 -5.7 -21 -14 -4.9 -57 24
0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.3
2.6 1.3 -0.5 -0.8 -1.8 -1.5 -1.7 -3.2 -2.9 -1.3 -1.2 -1.5 -0.4
-0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.1 0.0 0.0 0.0 30 9.9
40 68 -3.9 40 62 2.6 1.3 -0.1 -0.6 -1.5 -0.5 22 39 54 81 3.8 -0.6 8.2 61 28
27 23 -33 9.9 41 -47 6.2 -9.9 4.4 -3.2 -4.0 12 22 38 59 -32 -2.9 -49 -46 32
-14 -15 -45 -19 -44 -11 -15 -24 0.0 -1.6 -3.6 -9.7 -17 -16 -20 -28 3.0 -57 -54 -24

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?